(Press-News.org) We live in fear of 'superbugs': infectious bacteria that don't respond to treatment by antibiotics, and can turn a routine hospital stay into a nightmare. A 2015 Health Canada report estimates that superbugs have already cost Canadians $1 billion, and are a "serious and growing issue." Each year two million people in the U.S. contract antibiotic-resistant infections, and at least 23,000 people die as a direct result.
But tests for antibiotic resistance can take up to three days to come back from the lab, hindering doctors' ability to treat bacterial infections quickly. Now Ph.D. researcher Justin Besant and his team at the University of Toronto have designed a small and simple chip to test for antibiotic resistance in just one hour, giving doctors a shot at picking the most effective antibiotic to treat potentially deadly infections. Their work was published this week in the international journal Lab on a Chip.
Resistant bacteria arise in part because of imprecise use of antibiotics -- when a patient comes down with an infection, the doctor wants to treat it as quickly as possible. Samples of the infectious bacteria are sent to the lab for testing, but results can take two to three days. In the meantime, the doctor prescribes her patient a broad-spectrum antibiotic. Sometimes the one-size-fits-all antibiotic works and sometimes it doesn't, and when the tests come back days later, the doctor can prescribe a specific antibiotic more likely to kill the bacteria.
"Guessing can lead to resistance to these broad-spectrum antibiotics, and in the case of serious infections, to much worse outcomes for the patient," says Besant. "We wanted to determine whether bacteria are susceptible to a particular antibiotic, on a timescale of hours, not days."
The problem with most current tests is the time it takes for bacteria to reproduce to detectable levels. Besant and his team, including his supervisor Professor Shana Kelley of the Institute for Biomaterials & Biomedical Engineering and the Faculties of Pharmacy and Medicine, and Professor Ted Sargent of The Edward S. Rogers Sr. Department of Electrical & Computer Engineering, drew on their collective expertise in electrical and biomedical engineering to design a chip that concentrates bacteria in a miniscule space--just two nanolitres in volume--in order to increase the effective concentration of the starting sample.
They achieve this high concentration by 'flowing' the sample, containing the bacteria to be tested, through microfluidic wells patterned onto a glass chip. At the bottom of each well a filter, composed of a lattice of tiny microbeads, catches bacteria as the sample flows through. The bacteria accumulate in the nano-sized well, where they're trapped with the antibiotic and a signal molecule called resazurin.
Living bacteria metabolize resazurin into a form called resorufin, changing its electrochemical signature. If the bacteria are effectively killed by the antibiotic, they stop metabolizing resazurin and the electrochemical signature in the sample stays the same. If they are antibiotic-resistant, they continue to metabolize resazurin into resorufin, altering its electrochemical signature. Electrodes built directly into the chip detect the change in current as resazurin changes to resorcin.
"This gives us two advantages," says Besant. "One, we have a lot of bacteria in a very small space, so our effective starting concentration is much higher. And two, as the bacteria multiply and convert the resazurin molecule, it's effectively stuck in this nanolitre droplet--it can't diffuse away into the solution, so it can accumulate more rapidly to detectable levels."
"Our approach is the first to combine this method of increasing sample concentration with a straightforward electrochemical readout," says Professor Sargent. "We see this as an effective tool for faster diagnosis and treatment of commonplace bacterial infections."
Rapid alternatives to existing antibiotic resistance tests rely on fluorescence detection, requiring expensive and bulky fluorescence microscopes to see the result.
"The electronics for our electrochemical readout can easily fit in a very small benchtop instrument, and this is something you could see in a doctor's office, for example," says Besant. "The next step would be to create a device that would allow you to test many different antibiotics at many different concentrations, but we're not there yet."
INFORMATION:
Chronic pain affects hundreds of millions of people worldwide and is a major cause of disability, causing more disability than cancer and heart disease. Canadian researchers, including Michael Salter at SickKids are shedding light on the molecular dynamics of chronic pain. They have uncovered a critical role for a class of cells present in the brain and spinal cord, called microglia, in pain. They have found microglia-to-neuron-signaling to be crucial in the development of pain hypersensitivity after injury, but also for one of the paradoxical effects morphine and other ...
Promising results from a trial of a new stem-cell based therapy for a rare and debilitating skin condition have been published in the Journal of Investigative Dermatology. The therapy, involving infusions of stem cells, was found to provide pain relief and to reduce the severity of this skin condition for which no cure currently exists.
The clinical trial, led by King's College London in collaboration with Great Ormond Street Hospital (GOSH), recruited 10 children with recessive dystrophic epidermolysis bullosa (RDEB).
RDEB is a painful skin disease in which very minor ...
MicroRNA can serve as a "decoder ring" for understanding complex biological processes, a team of New York University chemists has found. Their study, which appears in Proceedings of the National Academy of Sciences, points to a new method for decrypting the biological functions of enzymes and identifying those that drive diseases.
The research focuses on a particular class of enzymes that biosynthesize carbohydrates (i.e. glycans)--complex biological molecules controlling multiple aspects of cell biology--as well as on their attendant microRNA (miRNA), which are regulatory ...
MADISON - A century spent treating wildfires as emergencies to be stamped out may have cost Central Wisconsin a natural setting that was common and thriving before the state was settled.
Pine barrens once stretched like a scarf around the state's neck, from the northeast down across Central Wisconsin and up again northwest to Lake Superior. As recently as the 1950s, University of Wisconsin-Madison surveys conducted by botany Professor John Curtis and graduate student James Habeck described the sandy, open spaces dotted with pin oak and jack pine and dashed with the lavender ...
MADISON - Portable electronics - typically made of non-renewable, non-biodegradable and potentially toxic materials - are discarded at an alarming rate in consumers' pursuit of the next best electronic gadget.
In an effort to alleviate the environmental burden of electronic devices, a team of University of Wisconsin-Madison researchers has collaborated with researchers in the Madison-based U.S. Department of Agriculture Forest Products Laboratory (FPL) to develop a surprising solution: a semiconductor chip made almost entirely of wood.
The research team, led by UW-Madison ...
Boulder, Colo., USA - Lithosphere articles posted 13 and 21 May cover several fascinating locations and geodynamic processes. One study investigates the kinematic evolution of the Himalayan orogen at a site in Nepal. Another paper addresses the "unroofing" of the Klamath Mountains in northern California/southern Oregon, USA. In the East African Rift area, researchers are examining how vegetation mediates slope erosion. Another group focusses on the largest salt lake of the Mediterranean region, Lake Tuz, Turkey.
All recently posted Lithosphere articles are listed below.
Abstracts ...
Stem cell transplant is essential in the care of many blood cancers, but leaves patients requiring in-home care for months after. Frequently the role of caregiver falls to family or other committed members of the patient's support network. Previous work shows dramatically increased stress in cancer caregivers, directly impacting the caregiver and indirectly impacting the cancer patient via reduced quality of care. A randomized control trial funded by the National Cancer Institute by members of the University of Colorado Cancer Center, published in the journal Bone Marrow ...
New York, NY - NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center will have a high profile at the 51st Annual Meeting of the American Society for Clinical Oncology (ASCO), with researchers presenting close to 30 abstracts accepted for oral, poster and publication presentations.
Leading the way are eight oral abstract and poster presentations on melanoma for which an NYU Langone researcher is either a senior, lead or contributing author. While many of these studies are multi-institutional, five poster presentations are led by the Perlmutter ...
Despite early promise of benefits, soy doesn't help lung function
Lifestyle and diet may also affect asthma control
Study highlights importance of placebo-controlled studies
CHICAGO --- Despite previous findings suggesting a link between soy intake and decreased asthma severity, a new study from Northwestern Medicine and the American Lung Association Asthma Clinical Research Network shows soy supplements do not improve lung function for patients with asthma.
The paper, published May 26 in the Journal of the American Medical Association (JAMA), highlights the ...
While most surviving spouses had more depression symptoms following the death of their partner regardless of hospice use, researchers found a modest reduction in depressive symptoms among some surviving spouses of hospice users compared with nonhospice users, according to an article published online by JAMA Internal Medicine.
The Institute of Medicine's report on improving the quality of care near the end of life highlights the need for supporting family caregivers. Core components of high-quality hospice care include counseling services for family members before and ...
